Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013, Article ID 635960, 6 pages
http://dx.doi.org/10.1155/2013/635960
Research Article

A Single-Center, Randomized Double-Blind Placebo-Controlled Study Evaluating the Effects of Poly-Gamma-Glutamate on Human NK Cell Activity after an 8-Week Oral Administration in Healthy Volunteers

1Department of Family Medicine, Seoul St. Mary's Hospital, The Catholic University, Seoul 137-701, Republic of Korea
2Viral Infectious Disease Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon 305-806, Republic of Korea
3Clinical Trials Center, Department of Pharmacology, College of Medicine, Chungnam National University, Daejeon 301-721, Republic of Korea
4Department of Microbiology and Molecular Genetics, Michigan State University, East Lansing, MI 48824, USA
5Department of Advanced Fermentation Fusion, Kookmin University, Seoul 136-702, Republic of Korea
6BioLeaders Corporation, Daejeon 305-500, Republic of Korea
7Infection and Immunity Research Center, Korea Research Institute of Bioscience and Biotechnology, 125 Gwahak-ro, Yuseong-gu, Daejeon 305-806, Republic of Korea

Received 30 October 2013; Accepted 13 November 2013

Academic Editor: Jae Youl Cho

Copyright © 2013 Kyung-Soo Kim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. B. Oppermann-Sanio and A. Steinbuchel, “Occurrence, functions and biosynthesis of polyamides in microorganisms and biotechnological production,” Naturwissenschaften, vol. 89, no. 1, pp. 11–22, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. T. W. Kim, T. Y. Lee, H. C. Bae et al., “Oral administration of high molecular mass poly-gamma-glutamate induces NK cell-mediated antitumor immunity,” Journal of Immunology, vol. 179, no. 2, pp. 775–780, 2007. View at Google Scholar · View at Scopus
  3. T.-Y. Lee, Y.-H. Kim, S.-W. Yoon et al., “Oral administration of poly-gamma-glutamate induces TLR4- and dendritic cell-dependent antitumor effect,” Cancer Immunology, Immunotherapy, vol. 58, no. 11, pp. 1781–1794, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. E. Vivier, D. H. Raulet, A. Moretta et al., “Innate or adaptive immunity? the example of natural killer cells,” Science, vol. 331, no. 6013, pp. 44–49, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. J. S. Orange, “Formation and function of the lytic NK-cell immunological synapse,” Nature Reviews Immunology, vol. 8, no. 9, pp. 713–725, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. L. L. Lanier, “Up on the tightrope: natural killer cell activation and inhibition,” Nature Immunology, vol. 9, no. 5, pp. 495–502, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. M. A. Caligiuri, “Human natural killer cells,” Blood, vol. 112, no. 3, pp. 461–469, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. T. Bryceson and E. O. Long, “Line of attack: NK cell specificity and integration of signals,” Current Opinion in Immunology, vol. 20, no. 3, pp. 344–352, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. M. A. Cooper, T. A. Fehniger, and M. A. Caligiuri, “The biology of human natural killer-cell subsets,” Trends in Immunology, vol. 22, no. 11, pp. 633–640, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. G. Trinchieri, “Interleukin-12 and the regulation of innate resistance and adaptive immunity,” Nature Reviews Immunology, vol. 3, no. 2, pp. 133–146, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Boyum, “Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g,” Scandinavian Journal of Clinical and Laboratory Investigation, Supplement, vol. 97, pp. 77–89, 1968. View at Google Scholar · View at Scopus
  12. I. Hwang, T. Zhang, J. M. Scott et al., “Identification of human NK cells that are deficient for signaling adaptor FcRgamma and specialized for antibody-dependent immune functions,” International Immunology, vol. 24, no. 12, pp. 793–802, 2012. View at Publisher · View at Google Scholar
  13. V. E. Ooi and F. Liu, “Immunomodulation and anti-cancer activity of polysaccharide-protein complexes,” Current Medicinal Chemistry, vol. 7, no. 7, pp. 715–729, 2000. View at Google Scholar · View at Scopus
  14. S. P. Wasser, “Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides,” Applied Microbiology and Biotechnology, vol. 60, no. 3, pp. 258–274, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. A. T. Borchers, C. L. Keen, and M. E. Gershwini, “Mushrooms, tumors, and immunity: an update,” Experimental Biology and Medicine, vol. 229, no. 5, pp. 393–406, 2004. View at Google Scholar · View at Scopus
  16. F. P. Mceachrane-Gross, J. M. Liebschutz, and D. Berlowitz, “Use of selected complementary and alternative medicine (CAM) treatments in veterans with cancer or chronic pain: a cross-sectional survey,” BMC Complementary and Alternative Medicine, vol. 6, article 34, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Inglin, S. Amsler, F. Arigoni, C. Burton-Jeangros, C. Pargoux-Vallade, and A.-P. Sappino, “Complementary medicine use in oncology patients,” Revue Medicale Suisse, vol. 4, no. 158, pp. 1264–1269, 2008. View at Google Scholar · View at Scopus
  18. C. M. Mueller, P. L. Mai, J. Bucher, J. A. Peters, J. T. Loud, and M. H. Greene, “Complementary and alternative medicine use among women at increased genetic risk of breast and ovarian cancer,” BMC Complementary and Alternative Medicine, vol. 8, article 17, 2008. View at Publisher · View at Google Scholar · View at Scopus